Mitomycin Pyelocalyceal Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 40 mg
Reference Brands: Jelmyto (USA/EU)
Category: Oncology Cancer Care
Mitomycin pyelocalyceal is a formulation of mitomycin designed as a reverse-thermal hydrogel that becomes semi-solid at body temperature, allowing prolonged contact with the upper urinary tract. It is used for the treatment of low-grade upper tract urothelial cancer. The gel is instilled directly into the renal pelvis and calyces through a catheter and gradually dissolves to release the active drug. Mitomycin pyelocalyceal is available in Injection and strengths such as 40 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Mitomycin pyelocalyceal is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Mitomycin pyelocalyceal can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Mitomycin pyelocalyceal solution is used to treat low-grade upper tract urothelial cancer (LG-UTUC) in the renal pelvis or calyces. It works by directly targeting cancer cells within the upper urinary tract.
It is made from mitomycin C formulated in a thermosensitive gel. The gel remains liquid during preparation and becomes semi-solid at body temperature, allowing it to stay in place within the pyelocalyceal system for sustained drug exposure.
The trade name is Jelmyto.
It is developed and manufactured by UroGen Pharma.
The generic name is Mitomycin for pyelocalyceal solution (mitomycin C).
The brand name is Jelmyto.
It is manufactured by UroGen Pharma in its regulated pharmaceutical production facilities and supplied to hospitals and clinics for administration through a catheter into the renal pelvis.
Related Products
Tafasitamab‑Cxix
Strength:
200 mg
Form: Injection
Reference Brands: Monjuvi (USA), Minjuvi (EU)
View Details
Dordaviprone Hydrochloride
Strength:
125 mg
Form: Capsules
Reference Brands: Modeyso (USA)
View Details
Quick Response Guaranteed | Verified Suppliers
